Eisai Explores New Business Model
This article was originally published in The Pink Sheet Daily
Executive Summary
Facing stronger global competition and a patent cliff for Alzheimer’s standard Aricept, Tokyo company moves to patient-centered model, proposes special communities for dementia patients.
You may also be interested in...
Eisai Plans R&D Structure Revamp, Hoping To Turn The Development Tide
TOKYO - Eisai CEO Haruo Naito unveiled plans to revamp the company's research and development structure in hopes of having his employees produce better results, Naito told analysts Feb. 27 in Tokyo
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products